Risperidone in Bipolar Disorders

Czech version

Authors: E. Češková
Authors‘ workplace: Psychiatrická klinika LF MU a FN Brno, přednosta prof. MUDr. E. Češková, CSc.
Published in: Čes. a slov. Psychiat., , 2001, No. 8, pp. 418-421.
Category:

Overview

Risperidone is the first atypical antipsychotic registered as adjuvant treatment in bipolar disorder. The theoretical and practical reasons for this indication are summarized. Individual studieswith bipolar disorders demonstrating the justification for this indication are presented. Czechexperience is also included. Open, mostly short-term studies with risperidone in bipolar disorders, long-term open study and double-blind studies where risperidone was administered in indications mentioned as monotherapy and in combination with mood stabilizers are reviewed indetail.

Key words:
risperidone, bipolar disorder, mood stabilizers, manic symptomatology.

Full text is not available online.

If interested in a scan of this journal, contact NTO ČLS JEP.

Labels

Addictology Paediatric psychiatry Psychiatry

Mirtazapine in Routine Psychiatric Practice

Olanzapine in the Treatment of Psychoses in Adolescence

The Use of Acamprosate Sublingually as a CrisisIntervention for Craving

Lower Cholesterol Levels in Delinquents with Affective Violent Offences as Compared with Delinquents without Violent Offences and a Control Group

Interactions between Cigarette Smoking and Antipsychotics

Importance of Anamnestic Exploration in the Diagnosis of the Sexual Orientation and Paraphilia

Uptake of Thyroid Hormones by Erythrocytes in Relation to Depres-sion

Article was published in

Czech and Slovak Psychiatry

2001 Issue 8